Skip To Main Content
Jorga Fialova on Muck Rack

Jorga Fialova

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jorga

Contact Jorga, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Super‐Response to Guselkumab Treatment in Patients With Moderate‐to‐Severe Psoriasis: Real‐World Data With Up to Five Years of Follow‐Up in The Czech Republic

|
By Martina Kojanova, Daniela Pejrilova, Jorga Fialova, Petra Cetkovska
| Wiley Online Library Verified
1 Introduction Psoriasis is a chronic immune-mediated skin disease with significant impact on patients' physical and mental well-being [1, 2]. Since the introduction of biologics in the early 2000s, treatment outcomes have improved substantially [3, 4]. Newer classes of biologics, including interleukin (IL)-17 and IL-23 inhibitors, offer targeted and durable treatment options for moderate-to-severe psoriasis [5-9].
Open in Who Shared Issue with article?
See all 1 articles